| Dr Theron Blickenstaff, MD | |
|
709 Clandon Dr, Kingsport, TN 37660-5036 | |
| (423) 378-3267 | |
| Not Available |
| Full Name | Dr Theron Blickenstaff |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Occupational Medicine |
| Location | 709 Clandon Dr, Kingsport, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467640375 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083X0100X | Preventive Medicine - Occupational Medicine | 14559 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Theron Blickenstaff, MD 709 Clandon Dr, Kingsport, TN 37660-5036 Ph: (423) 378-3267 | Dr Theron Blickenstaff, MD 709 Clandon Dr, Kingsport, TN 37660-5036 Ph: (423) 378-3267 |
News Archive
Peter B. Bach, M.D., of the Memorial Sloan-Kettering Cancer Center, New York, and colleagues conducted a systematic review to examine the evidence regarding the benefits and harms of low-dose computerized tomography (LDCT) screening for lung cancer, which is the leading cause of cancer death. "Most patients are diagnosed with advanced disease, resulting in a very low 5-year survival rate," the authors write.
Cornerstone Pharmaceuticals, Inc., a leader in cancer metabolism-based therapeutics, today announced encouraging results of a preclinical toxicity study of azide drug-loaded Emulsiphan nano emulsions conducted with the National Cancer Institute (NCI) under a Collaboration Agreement. Emulsiphan is Cornerstone's proprietary nanoparticle drug delivery system.
IASIS Healthcare LLC today announced financial and operating results for the fiscal second quarter and six months ended March 31, 2012. In the first quarter of 2012, IASIS adopted accounting guidance that results in the classification of the provision for bad debts as a revenue deduction rather than an operating expense, and such guidance has been applied to the financial statements of both the current and prior year periods.
At a time when the effects of paediatric oncology research have meant that more and more children survive cancer, its funding is too low and dependent on short-term grants to be able to sustain this improvement in the long-term, says a report supported by the EU-funded 7th Framework Programme project Eurocancercoms and published on-line in ecancer today.
A special cream enriched with bacteria-busting viruses has been developed by scientists in Britain and it could eradicate deadly superbugs such as MRSA from hospitals.
› Verified 4 days ago
Dr. Ibrahim Heiba, MD, MPH Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 S Wilcox Dr, Bldg 215, Kingsport, TN 37662 Phone: 423-229-5448 Fax: 423-229-1684 |